ignore qcor's history of huge growth, Acthat's 21 FDA approved indications (of which only a handful have been marketed and sold to date), humongous free cash flow generation, ROE's of almost 100%, large share buy-backs and zero debt.
Qcor is curently paying $1.00/share annual dividend, which equates to about 3% annual yield.
When a company like Qcor is debt-free and throwing off this much cash, it is next to a certainty the dividend wont be reduced and perhaps real good probabilities the dividend may increase.
So you don't have to believe in Qcor's growth prospects at all....just buy Qcor for the nice yield. And if the much more optimistic sorts, like myself, are correct, you get massive growth for FREE.
So, capture the 3%, collect the dividend and go away. Within a year or so, the 3% may be a rounding error compared to the huge potential of Qcor?